pPV-TetO-SpCas9-GR-iC-ERiP (CRONUS-Puro) Citations (2)

Originally described in: Site-specific randomization of the endogenous genome by a regulatable CRISPR-Cas9 piggyBac system in human cells.
Ishida K, Xu H, Sasakawa N, Lung MSY, Kudryashev JA, Gee P, Hotta A Sci Rep. 2018 Jan 10;8(1):310. doi: 10.1038/s41598-017-18568-4. PubMed Journal

---

Articles Citing pPV-TetO-SpCas9-GR-iC-ERiP (CRONUS-Puro)

Articles
A novel ADPKD model using kidney organoids derived from disease-specific human iPSCs. Shimizu T, Mae SI, Araoka T, Okita K, Hotta A, Yamagata K, Osafune K. Biochem Biophys Res Commun. 2020 Sep 3;529(4):1186-1194. doi: 10.1016/j.bbrc.2020.06.141. Epub 2020 Aug 4. PubMed
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice. Kenjo E, Hozumi H, Makita Y, Iwabuchi KA, Fujimoto N, Matsumoto S, Kimura M, Amano Y, Ifuku M, Naoe Y, Inukai N, Hotta A. Nat Commun. 2021 Dec 8;12(1):7101. doi: 10.1038/s41467-021-26714-w. PubMed

If you have published an article using this material, please email us at to have your article added to this page.